Last reviewed · How we verify
E. Coli Gynecological Infections
Approved treatments
- Unasyn · Bristol-Myers Squibb
- Unasyn · Pfizer
- Fortaz · Pai Holdings Pharm
Fortaz works by binding to penicillin-binding proteins on bacterial cell walls, preventing them from forming a strong cell wall and ultimately leading to bacterial cell death. - Fortaz · Pai Holdings Pharm
Bactericidal agent inhibiting bacterial cell wall synthesis with beta-lactamase resistance. - Ceftazidim · Tel-Aviv Sourasky Medical Center
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- E. Coli Gynecological Infections patent landscape — cliff calendar, originator estates, attackable patents
- E. Coli Gynecological Infections treatment landscape brief
- E. Coli Gynecological Infections treatment updates RSS
Frequently asked questions about E. Coli Gynecological Infections
What drugs treat E. Coli Gynecological Infections?
Tracked treatments include Unasyn, Fortaz, Ceftazidim.
What is the treatment for E. Coli Gynecological Infections?
Standard treatment for E. Coli Gynecological Infections includes Unasyn, Fortaz, Ceftazidim. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: E. Coli Gynecological Infections patent cliff · E. Coli Gynecological Infections CI report
- Treatment: Unasyn · Bristol-Myers Squibb
- Treatment: Unasyn · Pfizer
- Treatment: Fortaz · Pai Holdings Pharm
- Treatment: Fortaz · Pai Holdings Pharm
- Treatment: Ceftazidim · Tel-Aviv Sourasky Medical Center
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing